Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis.

  title={Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis.},
  author={JAMES L. Smith and Darrell O Bayles},
  journal={Journal of food protection},
  volume={70 7},
Irritable bowel syndrome (IBS) is a commonly diagnosed disease characterized by gastrointestinal symptoms that may be associated with psychological illness and emotional problems. The prevalence rate worldwide for IBS ranges from 10 to 20% and is higher for women than for men. IBS imposes a substantial financial burden on both patients and employers because of increased medical costs and decreased work productivity. Recent studies indicate that inflammatory processes involving the… 

Tables from this paper

[Post-infectious irritable bowel syndrome].
Histopathologic data demonstrate a low-grade mucosal inflammation in a subset of patients with IBS and the use of probiotics or non absorbable antibiotics during the acute infective episode could play a preventive role.
Disease burden of post-infectious irritable bowel syndrome in The Netherlands
The aim of this study was to estimate the burden of PI-IBS caused by the pathogens Campylobacter, Salmonella and Shigella, and to compare this with other outcomes associated with these pathogens.
Post-infectious Irritable bowel syndrome
Many animal and human studies have shown the presence of increased infiltration of inflammatory cells and hyperplasia of enterochromaffin cells in the intestinal mucosa after acute gastroenteritis.
Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome
Different methods have been used for the development of post-infectious or post-inflammatory IBS models, and each model has its weaknesses and strengths.
Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome
  • B. Cash
  • Medicine
    Current medical research and opinion
  • 2014
Probiotics and nonsystemic antibiotics have a place in IBS management;Limitations of evidence for probiotics include small populations analyzed and lack of clarity in optimal dosing regimen; antimicrobial evidence would benefit from better understanding of the effects of repeated treatment in patients with IBS.
Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects
The qPCR panel consisting of 12 assays for an extensive set of pathogenic microorganisms provides an efficient alternative to the conventional detection of gastrointestinal pathogens and could accelerate the initiation of targeted antibiotic therapy reducing the risk of post-infectious IBS (PI-IBS).
Long-term consequences of foodborne infections.
Review article Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome
The potential role of probiotics and antimicrobials for management of functional bowel disorders (FBDs) is reviewed, with a focus on irritable bowel syndrome (IBS), and preliminary data suggest that development of clinically relevant bacterial resistance is unlikely with rifaximin.
Idiopathic Colitis in Rhesus Macaques Is Associated With Dysbiosis, Abundant Enterochromaffin Cells and Altered T-Cell Cytokine Expression
Interestingly, colonic and ileal T-helper cells of animals with ICD manifested decreased capacity for expression of certain cytokines, in particular interleukin (IL)–4 and IL-13, and this data suggest new avenues to identify complex interactions involved in the etiology of recurring diarrhea in young rhesus macaques.
Antigenic Detection of Salmonella Infection Among Pediatric Patients with Acute Gastroenteritis
Evaluating the presence of Salmonella antigen in acute gastroenteritis in children admitted to a pediatric hospital found it present in five stool samples, all the patients show vomiting, fever, abdominal pain, and the stool consistency distributed to 75% watery and 24.5% loosely.


Prognosis in post-infective irritable bowel syndrome: a six year follow up study
Less than half of both PI-IBS and non-infective IBS cases recover over six years, and a history of anxiety and depression severe enough to warrant treatment may impair recovery but larger numbers are needed to prove this.
Post‐infectious irritable bowel syndrome in patients with Shigella infection
The role of bacterial gastroenteritis in the development of IBS and the risk factors for the development were verified and the clinical course of PI‐IBS was investigated.
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome
Individuals with PI-IBS are a clinically distinct subgroup characterized by diarrheal symptoms, less psychiatric illness, and increased serotonin-containing EC cells compared to those with non–PI- IBS.
The Incidence of Irritable Bowel Syndrome Among Community Subjects With Previous Acute Enteric Infection
The incidence of postinfectious irritable bowel syndrome among community subjects with positive stool studies is 3.7% and Fever during AEI was the only identifiable risk factor for developing post Infectious IBS.
Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.
PI-IBS is common after gastroenteritis from water contamination and often is diarrhea-predominant and characteristics of the acute illness identify patients at increased risk for PI-Ibs.
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study
A comparison cohort of patients aged 25 to 74 with a bacteriologically confirmed first episode of gastroenteritis is sampled from the source population, which contains clinical information on patients recorded by general practitioners in the United Kingdom.
Irritable bowel syndrome: a little understood organic bowel disease?
Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome
It is indicated that those patients who develop IBS post infection exhibit greater IL-1β mRNA expression, both during and after the infection, compared with individuals who do not develop PI-IBS.
Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?
Whether IBS and dyspepsia are different manifestations of the same disorder or whether they represent distinct clinical entities is discussed, and whether they are truly distinctclinical entities.
Postinfectious Irritable Bowel Syndrome—A Meta-Analysis
The results suggest that the long-term benefit of reduced PI-IBS may be gained from primary prevention of IGE, and a pooled risk estimate revealing a sevenfold increase in the odds of developing IBS following IGE.